Oral solid dose at a turning point: Scaling for the next generation of therapies
From patient-centric designs and sustainable changes to component shortages, anti-counterfeiting, and low-volume production, sponsors of oral solid dose pharmaceuticals and their CDMOs are navigating a number of packaging trends and challenges.
